Here's How Much $1000 Invested In Alnylam Pharmaceuticals 5 Years Ago Would Be Worth Today
Portfolio Pulse from Benzinga Insights
Alnylam Pharmaceuticals (NASDAQ:ALNY) has outperformed the market over the past 5 years with an average annual return of 17.23%, resulting in a $1000 investment growing to $2,260.70. The company currently has a market capitalization of $20.45 billion.
June 14, 2024 | 5:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Alnylam Pharmaceuticals has shown strong performance over the past 5 years with an average annual return of 17.23%, significantly outperforming the market.
The article highlights Alnylam Pharmaceuticals' strong historical performance, which is likely to positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100